CV Sciences disputes Extract Labs acquisition termination by Sellers; evaluating options

CV Sciences, Inc.

On Feb 5, 2025, Extract Labs owners informed CV Sciences they cannot close due to alleged failure to obtain bank consent, purportedly terminating the Stock Purchase Agreement.
CV Sciences disputes the Sellers' right to terminate and reserves all rights; evaluating legal options.
The Purchase Agreement was entered on Nov 21, 2024, for CV Sciences to acquire all outstanding shares of Extract Labs.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.